Six Tips for PACS Integration
Successfully upgrading and integrating your PACS requires proper preparation and maintenance.
Increased patient load, tightening reimbursement, and shrinking budgets can have multi-facility health systems searching for ways to maximize their bottom line. According to Applied Radiology, an up-to-date, integrated PACS could help grow your business.
A MarketsandMarkets study released in October revealed the enterprise PACS market is expected to balloon to more than $510 million by 2018, and a 2011 CapSite study estimated, at the time, 21 percent of U.S. hospitals and health systems would elect to change their PACS.
When selecting a new system, industry experts frequently recommend you consider functionality, accessibility, and scalability. However, there are a few specific tips that could make your decision easier.
1. Documentation: Be sure to create clear, detailed, comprehensive documentation about your enterprise workflow.
2. Standards: Whenever you can, opt for standards-based integration instead of proprietary integration. It will make future operations easier.
3. Test environment: Use live data in an integrated test environment.
4. Test plans: Create test plans for all your integrated systems based on your workflow documentation.
5. Vendor management: Whenever possible, coordinate any changes from your vendors with all the affected systems in advance.
6. Version control: Keep your systems up-to-date so you can successfully manage any upgrades or changes.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
